China Health Management Stock Year To Date Return
CNHC Stock | USD 0 0.00 0.00% |
China Health Management fundamentals help investors to digest information that contributes to China Health's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Health pink sheet.
China |
China Health Management Company Year To Date Return Analysis
China Health's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
Competition |
In accordance with the company's disclosures, China Health Management has a Year To Date Return of 0.0%. This indicator is about the same for the Technology Hardware, Storage & Peripherals average (which is currently at 0.0) sector and about the same as Information Technology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
All Next | Launch Module |
China Fundamentals
Profit Margin | (0.24) % | |||
Operating Margin | (0.21) % | |||
Current Valuation | 17.53 M | |||
Shares Outstanding | 81.15 M | |||
Price To Earning | (1.80) X | |||
Price To Sales | 3.18 X | |||
Revenue | 542.38 K | |||
Gross Profit | 108.47 K | |||
Net Income | (129.28 K) | |||
Current Ratio | 1.09 X | |||
Book Value Per Share | 0 X | |||
Earnings Per Share | (0) X | |||
Number Of Employees | 13 | |||
Beta | 1.28 | |||
Market Capitalization | 929.12 K | |||
Total Asset | 5.2 M | |||
Retained Earnings | (34.26 M) | |||
Working Capital | 5.16 M | |||
Current Asset | 9.37 M | |||
Current Liabilities | 4.21 M | |||
Z Score | -8.4 | |||
Net Asset | 5.2 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Management's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Management based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.